A Exploratory Phase 2,Placebo-controlled,Randomized,Double-blind,Multicenter,Parallel-group Study to Evaluate Efficacy and Safety of TMX-049 in Hyperuricemic Patients with or without Gout

Trial Profile

A Exploratory Phase 2,Placebo-controlled,Randomized,Double-blind,Multicenter,Parallel-group Study to Evaluate Efficacy and Safety of TMX-049 in Hyperuricemic Patients with or without Gout

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs TMX 049 (Primary) ; Febuxostat
  • Indications Gout; Hyperuricaemia
  • Focus Therapeutic Use
  • Sponsors Teijin Pharma
  • Most Recent Events

    • 01 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top